LEMAITRE VASCULAR, INC. Proceeds from (Repayments of) Other Long-term Debt
LEMAITRE VASCULAR, INC. (LMAT) reported Proceeds from (Repayments of) Other Long-term Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt · last filed 2024-02-29
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for the quarter ending 2022-09-30 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for the quarter ending 2022-06-30 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for the quarter ending 2022-03-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for fiscal 2023 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for fiscal 2021 was $39.00M.
- LEMAITRE VASCULAR, INC. proceeds from (repayments of) other long-term debt for fiscal 2020 was -$1.00M.
| Period end | Proceeds from (Repayments of) Other Long-term Debt 3 month | Proceeds from (Repayments of) Other Long-term Debt 6 month | Proceeds from (Repayments of) Other Long-term Debt 9 month | Proceeds from (Repayments of) Other Long-term Debt 12 month | Proceeds from (Repayments of) Other Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $78.00M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | $78.00M derived: sum of 3 quarters · filed 2024-02-29 | $55.00M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $78.00M derived: sum of 2 quarters · filed 2024-02-29 | $55.00M derived: sum of 3 quarters · filed 2024-02-29 | $46.00M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $55.00M derived: sum of 2 quarters · filed 2024-02-29 | $46.00M derived: sum of 3 quarters · filed 2024-02-29 | $39.00M 10-K · filed 2024-02-29 | -$39.00M 10-K · filed 2022-02-28 |
| 2021-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$32.00M derived: sum of 2 quarters · filed 2022-11-08 | -$39.00M 10-Q · filed 2022-11-08 | -$39.50M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$16.00M 10-Q · filed 2022-08-05 | -$16.50M derived: sum of 3 quarters · filed 2023-03-01 | -$17.00M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$7.00M 10-Q · filed 2022-05-10 | -$7.50M derived: sum of 2 quarters · filed 2023-03-01 | -$8.00M derived: sum of 3 quarters · filed 2023-03-01 | -$8.00M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$1.00M derived: sum of 2 quarters · filed 2023-03-01 | -$1.00M derived: sum of 3 quarters · filed 2023-03-01 | -$1.00M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$500.00K derived: sum of 2 quarters · filed 2021-11-04 | -$500.00K 10-Q · filed 2021-11-04 | -$500.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |